2-(3,4-Difluorophenyl)morpholine hydrochloride, 95.0%, 100mg

Ethyl 3-aminopyridazine-4-carboxylate, 95.0%, 100mg

5-Bromo-2-chloro-4-fluoropyridine, 95.0%, 250mg

(1R)-1-(2,5-DICHLOROPHENYL)ETHAN-1-AMINE HCL, 95%, 100mg

Copper(II) acetate monohydrate, min. 99%, pa, ACS, 250 g, plastic packaging.

Draining racks, Number of rods, 10 x 60 mm, 39 x 100 mm, 4 x 150 mm, 1 Piece

[1,2,4]Triazolo[4,3-a]pyridine-5-carboxylic acid, 95.0%, 5g

(2-Chloro-6-methyl-phenyl)-hydrazine; hydrochloride, 95.0%, 1g

1-Bromo-3-iodo-5-methylbenzene, 95.0%, 5g

Ethyl 2-amino-2-cyclohexylacetate, 98%, 250mg

2-(2-Amino-3-(4-bromobenzoyl)phenyl)acetic acid, 95.0%, 250mg

2-(Dimethylamino)-2-(4-methylbenzyl)-1-(4-morpholinophenyl)butan-1-one, >95.0%(HPLC)(qNMR), 25g

(R)-1-(3,5-Dimethoxyphenyl)ethanamine hydrochloride, 97%, 1g